BIOMERIEUX (BIM.PA) Fundamental Analysis & Valuation

EPA:BIM • FR0013280286

94 EUR
-1.05 (-1.1%)
Last: Mar 11, 2026, 07:00 PM

This BIM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BIM. BIM was compared to 65 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. BIM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year BIM was profitable.
  • BIM had a positive operating cash flow in the past year.
  • In the past 5 years BIM has always been profitable.
  • In the past 5 years BIM always reported a positive cash flow from operatings.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

  • With an excellent Return On Assets value of 7.13%, BIM belongs to the best of the industry, outperforming 81.54% of the companies in the same industry.
  • The Return On Equity of BIM (9.69%) is better than 63.08% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.60%, BIM is in the better half of the industry, outperforming 64.62% of the companies in the same industry.
Industry RankSector Rank
ROA 7.13%
ROE 9.69%
ROIC 8.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of BIM (9.77%) is better than 67.69% of its industry peers.
  • In the last couple of years the Profit Margin of BIM has declined.
  • BIM has a Operating Margin (12.81%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of BIM has declined.
  • BIM has a Gross Margin (56.73%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 12.81%
PM (TTM) 9.77%
GM 56.73%
OM growth 3Y-7.83%
OM growth 5Y-6.29%
PM growth 3Y-8.15%
PM growth 5Y-5.51%
GM growth 3Y0.45%
GM growth 5Y0.17%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. BIM.PA Health Analysis

2.1 Basic Checks

  • BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for BIM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 6.04 indicates that BIM is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.04, BIM belongs to the top of the industry, outperforming 87.69% of the companies in the same industry.
  • The Debt to FCF ratio of BIM is 1.02, which is an excellent value as it means it would take BIM, only 1.02 years of fcf income to pay off all of its debts.
  • BIM's Debt to FCF ratio of 1.02 is amongst the best of the industry. BIM outperforms 89.23% of its industry peers.
  • BIM has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • BIM has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. BIM outperforms 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.02
Altman-Z 6.04
ROIC/WACC1.07
WACC8.07%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • BIM has a Current Ratio of 2.39. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.39, BIM is doing good in the industry, outperforming 72.31% of the companies in the same industry.
  • BIM has a Quick Ratio of 1.48. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BIM (1.48) is better than 72.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.48
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. BIM.PA Growth Analysis

3.1 Past

  • BIM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.18%.
  • The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
  • BIM shows a small growth in Revenue. In the last year, the Revenue has grown by 2.26%.
  • BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)-8.18%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%9.2%
Revenue 1Y (TTM)2.26%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%-2.5%

3.2 Future

  • Based on estimates for the next years, BIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.24% on average per year.
  • BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.81% yearly.
EPS Next Y15.93%
EPS Next 2Y12.39%
EPS Next 3Y12.62%
EPS Next 5Y12.24%
Revenue Next Year4.21%
Revenue Next 2Y4.23%
Revenue Next 3Y5.32%
Revenue Next 5Y5.81%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2032 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. BIM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 24.35, the valuation of BIM can be described as rather expensive.
  • Based on the Price/Earnings ratio, BIM is valued a bit cheaper than the industry average as 63.08% of the companies are valued more expensively.
  • BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 19.28 indicates a rather expensive valuation of BIM.
  • BIM's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, BIM is valued a bit cheaper.
Industry RankSector Rank
PE 24.35
Fwd PE 19.28
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 70.77% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
  • 69.23% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.56
EV/EBITDA 11.61
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BIM's earnings are expected to grow with 12.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.53
PEG (5Y)2.23
EPS Next 2Y12.39%
EPS Next 3Y12.62%

4

5. BIM.PA Dividend Analysis

5.1 Amount

  • BIM has a yearly dividend return of 0.94%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.01, BIM pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, BIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

  • On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 26.69% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
  • The dividend of BIM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP26.69%
EPS Next 2Y12.39%
EPS Next 3Y12.62%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIM.PA Fundamentals: All Metrics, Ratios and Statistics

BIOMERIEUX

EPA:BIM (3/11/2026, 7:00:00 PM)

94

-1.05 (-1.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-27
Earnings (Next)04-23
Inst Owners20.39%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap11.13B
Revenue(TTM)4.07B
Net Income(TTM)397.50M
Analysts75.29
Price Target121.1 (28.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP26.69%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.76%
PT rev (3m)-4.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.56%
EPS NY rev (3m)-3.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.8%
Revenue NY rev (3m)-2.91%
Valuation
Industry RankSector Rank
PE 24.35
Fwd PE 19.28
P/S 2.73
P/FCF 24.56
P/OCF 14.11
P/B 2.71
P/tB 3.74
EV/EBITDA 11.61
EPS(TTM)3.86
EY4.11%
EPS(NY)4.88
Fwd EY5.19%
FCF(TTM)3.83
FCFY4.07%
OCF(TTM)6.66
OCFY7.09%
SpS34.38
BVpS34.66
TBVpS25.12
PEG (NY)1.53
PEG (5Y)2.23
Graham Number54.86
Profitability
Industry RankSector Rank
ROA 7.13%
ROE 9.69%
ROCE 11.56%
ROIC 8.6%
ROICexc 9.85%
ROICexgc 13.8%
OM 12.81%
PM (TTM) 9.77%
GM 56.73%
FCFM 11.13%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-7.83%
OM growth 5Y-6.29%
PM growth 3Y-8.15%
PM growth 5Y-5.51%
GM growth 3Y0.45%
GM growth 5Y0.17%
F-Score8
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.02
Debt/EBITDA 0.34
Cap/Depr 76.48%
Cap/Sales 8.24%
Interest Coverage 250
Cash Conversion 82.14%
Profit Quality 113.96%
Current Ratio 2.39
Quick Ratio 1.48
Altman-Z 6.04
F-Score8
WACC8.07%
ROIC/WACC1.07
Cap/Depr(3y)127.23%
Cap/Depr(5y)260.6%
Cap/Sales(3y)8.71%
Cap/Sales(5y)8.54%
Profit Quality(3y)72.77%
Profit Quality(5y)69.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.18%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%9.2%
EPS Next Y15.93%
EPS Next 2Y12.39%
EPS Next 3Y12.62%
EPS Next 5Y12.24%
Revenue 1Y (TTM)2.26%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%-2.5%
Revenue Next Year4.21%
Revenue Next 2Y4.23%
Revenue Next 3Y5.32%
Revenue Next 5Y5.81%
EBIT growth 1Y-11.42%
EBIT growth 3Y-3.89%
EBIT growth 5Y-1.17%
EBIT Next Year62.39%
EBIT Next 3Y25.75%
EBIT Next 5Y21.16%
FCF growth 1Y40.9%
FCF growth 3Y33.97%
FCF growth 5Y8.21%
OCF growth 1Y18.13%
OCF growth 3Y18.39%
OCF growth 5Y6.23%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 5 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 4 / 10 and the dividend payout ratio is 26.69%.